Rubicon Organics Clears Conditions for Hope Facility Acquisition, Advancing Growth Strategy
Rubicon Organics (ROMJF) has cleared all conditions precedent for acquiring the Hope Facility from Medipharm Labs Inc. The facility is a 47,500 square foot indoor cultivation facility located in Hope, British Columbia. This strategic acquisition is expected to significantly expand Rubicon's premium cannabis production capacity.
The company, which specializes in organic certified and premium cannabis products, anticipates closing the acquisition in the second quarter. CEO Margaret Brodie emphasized that this acquisition represents a pivotal step in meeting growing demand for their premium brands, accelerating innovation, and creating long-term shareholder value.
Rubicon Organics (ROMJF) ha completato tutte le condizioni preliminari per l'acquisizione della Hope Facility da Medipharm Labs Inc. La struttura è un impianto di coltivazione indoor di 4.413 metri quadrati situato a Hope, nella British Columbia. Questa acquisizione strategica dovrebbe ampliare significativamente la capacità produttiva di cannabis premium di Rubicon.
L'azienda, specializzata in prodotti di cannabis certificati biologici e di alta qualità, prevede di concludere l'acquisizione nel secondo trimestre. La CEO Margaret Brodie ha sottolineato che questa operazione rappresenta un passo fondamentale per soddisfare la crescente domanda dei loro marchi premium, accelerare l'innovazione e creare valore a lungo termine per gli azionisti.
Rubicon Organics (ROMJF) ha cumplido todas las condiciones previas para adquirir la Hope Facility de Medipharm Labs Inc. La instalación es un centro de cultivo interior de 4,413 metros cuadrados ubicado en Hope, Columbia Británica. Esta adquisición estratégica se espera que amplíe significativamente la capacidad de producción de cannabis premium de Rubicon.
La compañía, especializada en productos de cannabis orgánicos certificados y de alta calidad, anticipa cerrar la adquisición en el segundo trimestre. La CEO Margaret Brodie destacó que esta adquisición representa un paso crucial para satisfacer la creciente demanda de sus marcas premium, acelerar la innovación y generar valor a largo plazo para los accionistas.
Rubicon Organics (ROMJF)는 Medipharm Labs Inc.로부터 Hope Facility 인수에 필요한 모든 조건을 충족했습니다. 이 시설은 브리티시컬럼비아 주 호프에 위치한 4,413평방미터 규모의 실내 재배 시설입니다. 이번 전략적 인수는 Rubicon의 프리미엄 대마초 생산 능력을 크게 확장할 것으로 기대됩니다.
유기농 인증 및 프리미엄 대마초 제품을 전문으로 하는 회사는 2분기 내 인수를 완료할 예정입니다. CEO 마가렛 브로디는 이번 인수가 프리미엄 브랜드에 대한 증가하는 수요를 충족하고 혁신을 가속화하며 장기적인 주주 가치를 창출하는 중요한 단계라고 강조했습니다.
Rubicon Organics (ROMJF) a rempli toutes les conditions préalables à l'acquisition de la Hope Facility auprès de Medipharm Labs Inc. L'installation est un centre de culture intérieure de 4 413 mètres carrés situé à Hope, en Colombie-Britannique. Cette acquisition stratégique devrait considérablement augmenter la capacité de production de cannabis premium de Rubicon.
L'entreprise, spécialisée dans les produits de cannabis biologiques certifiés et haut de gamme, prévoit de finaliser l'acquisition au deuxième trimestre. La PDG Margaret Brodie a souligné que cette acquisition représente une étape clé pour répondre à la demande croissante de leurs marques premium, accélérer l'innovation et créer une valeur durable pour les actionnaires.
Rubicon Organics (ROMJF) hat alle aufschiebenden Bedingungen für den Erwerb der Hope Facility von Medipharm Labs Inc. erfüllt. Die Anlage ist eine 4.413 Quadratmeter große Indoor-Anbauanlage in Hope, British Columbia. Diese strategische Übernahme wird voraussichtlich die Produktionskapazität von Rubicons Premium-Cannabis erheblich erweitern.
Das Unternehmen, das sich auf biologisch zertifizierte und hochwertige Cannabisprodukte spezialisiert hat, plant den Abschluss der Übernahme im zweiten Quartal. CEO Margaret Brodie betonte, dass diese Akquisition einen entscheidenden Schritt darstellt, um die wachsende Nachfrage nach ihren Premium-Marken zu erfüllen, Innovationen zu beschleunigen und langfristigen Aktionärswert zu schaffen.
- Acquisition of a large 47,500 sq ft operational cultivation facility to expand production capacity
- Strategic expansion to meet growing market demand for premium brands
- Purpose-built facility that's already operational, reducing setup time and costs
- Financial terms and acquisition cost not disclosed
- Integration costs and timeline uncertainties may impact short-term operations
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce the removal of all conditions precedent, related to its previously announced purchase and sale agreement (the “PSA”) with Medipharm Labs Inc. for an operational, purpose-built 47,500 square foot indoor cultivation facility in Hope, British Columbia (the “Hope Facility”).
This milestone clears the path for Rubicon Organics to finalize the acquisition of the Hope Facility, which is expected to significantly expand the Company’s premium production capacity and support its growth strategy.
“Our acquisition of the Hope Facility marks a pivotal step forward, for Rubicon Organics,” said Margaret Brodie, Chief Executive Officer of Rubicon Organics. “The Hope Facility enhances our ability to meet growing demand for our premium brands, accelerate innovation, and drive long-term value for shareholders.”
The Company expects to close the acquisition of the Hope Facility in the second quarter and will provide further updates as they become available.
About the Hope Facility
The Hope Facility spans 47,500 square feet of purpose-built indoor capacity and is equipped with advanced cultivation technology, supporting Rubicon Organics’ strategy to expand its premium product offerings and increasing supply to meet rising demand. The Company estimates annual production capacity of the Hope Facility to be up to 4,500 kgs and expects Rubicon Organics’ first harvests by the end of 2025, with revenue realized in early 2026.
The Company will provide further updates on the transaction and production timelines in the coming months.
ABOUT RUBICON ORGANICS INC.
Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare™ Organic, its premium brand 1964 Supply Co™, and its cannabis wellness brand Wildflower™ in addition to the Company’s mainstream brand Homestead Cannabis Supply™.
The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada.
CONTACT INFORMATION
Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com
The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ expectation of finalizing the Hope Facility acquisition; of bolstering growth, market leadership, and new innovation from the acquisition of the Hope Facility, and goal of achieving industry leading profitability are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. The forward-looking information in this press release is based on certain assumptions that management considers reasonable under the circumstances, including the Company’s acquisition of the Hope Facility, the Hope Facility strengthening the Company’s premium production capacity, growing demand of the Company’s leading brand portfolio, the acceleration of the Company’s growth beyond its existing footprint, the intended use of the Hope Facility, the ability of the Company to successfully complete the acquisition of the Hope Facility and the expected timing of completion of the acquisition of the Hope Facility. These assumptions include securing necessary financing, the impact of the Hope Facility on the Company’s business, completing due diligence, obtaining required regulatory approvals such as licensing, and fulfilling other customary closing conditions. These statements are based on current expectations, estimates, and projections about the Company’s business and the industry in which it operates. Risks and uncertainties associated with the forward-looking information in this press release include, among others, risks related to regulatory approvals, changes in market conditions, competition, supply chain disruptions, the Company’s ability to maintain certification standards, and the successful implementation of its business strategy. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
FAQ
What is the size and location of the Hope Facility that ROMJF is acquiring?
When does Rubicon Organics expect to close the Hope Facility acquisition?
Who is the current CEO of Rubicon Organics (ROMJF)?
What is the purpose of ROMJF's Hope Facility acquisition?
Who is selling the Hope Facility to Rubicon Organics?
